PubMed=10811875; DOI=10.1073/pnas.090097797; PMCID=PMC18535
Xu W.-D., Angelis K., Danielpour D., Haddad M.M., Bischof O., Campisi J., Stavnezer E., Medrano E.E.
Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Proc. Natl. Acad. Sci. U.S.A. 97:5924-5929(2000)

PubMed=11719430
Reed J.A., Bales E.S., Xu W.-D., Okan N.A., Bandyopadhyay D., Medrano E.E.
Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.
Cancer Res. 61:8074-8078(2001)

PubMed=14583455
Chen D.-H., Xu W.-D., Bales E.S., Colmenares C., Conacci-Sorrell M., Ishii S., Stavnezer E., Campisi J., Fisher D.E., Ben-Ze'ev A., Medrano E.E.
SKI activates Wnt/beta-catenin signaling in human melanoma.
Cancer Res. 63:6626-6634(2003)

PubMed=15313901; DOI=10.1158/0008-5472.CAN-04-0230
Garcia M., Fernandez-Garcia N.I., Rivas V., Carretero M., Escamez M.J., Gonzalez-Martin A., Medrano E.E., Volpert O.V., Jorcano J.L., Jimenez B., Larcher F., Del Rio Nechaevsky M.
Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
Cancer Res. 64:5632-5642(2004)